Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029
Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Infectious Disease In vitro diagnostic (IVD) is a type of test that is performed on samples taken from the human body, such as blood taken from a vein or fingerstick or swabs of mucus from inside the nose or back of the throat. Infectious Disease In vitro diagnostic is used to diagnose various infectious diseases that are present in an individual’s body. The increasing geriatric population, rising incidences of target infections, coupled with the growing awareness about early diagnosis are the primary factors that are burgeoning the market demand across the globe.
As per the World Health Organization (WHO), the global geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Accordingly, the increasing geriatric population is more prone to get affected by a wide range of infectious diseases due to low immunity, which is accelerating the growth of the Infectious Disease In Vitro Diagnostics Market globally. In addition, growing demand for PoC facilities, as well as increasing funding for R&D activities are creating various lucrative opportunities for market growth over the forecasting years. However, the high cost of IVD tests stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Infectious Disease In Vitro Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the rising emphasis on disease surveillance by conducting various tests and early diagnostics, geographic expansion of key players, along with the presence of favorable regulatory framework across the region. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as increasing population, rising prevalence of target diseases and infections, and rising healthcare expenditure are bolstering regional market growth in the forthcoming years.
Major market players included in this report are:
QIAGEN
bioMйrieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Recent Developments in the Market:
In January 2020, Quest Diagnostics entered into a collaborative agreement with Memorial Hermann Health System to offer enhanced, high-quality, cost-efficient, and innovative diagnostic services for 21 hospital laboratories across the Huston region. The objective of this initiative is geographical expansion.
In June 2022, Eurobio Scientific declared the introduction of two novel tests for SARS-CoV-2 (for variants Omicron BA.2, BA.1, and BA.4/BA.5) and Monkeypox in France.
Global Infectious Disease In Vitro Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Application, Technology, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Instruments
Reagents
Software
By Application:
Respiratory Virus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis
COVID-19
Others
By Technology:
Immunoassay
Molecular Diagnostics
Others
Microbiology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
As per the World Health Organization (WHO), the global geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Accordingly, the increasing geriatric population is more prone to get affected by a wide range of infectious diseases due to low immunity, which is accelerating the growth of the Infectious Disease In Vitro Diagnostics Market globally. In addition, growing demand for PoC facilities, as well as increasing funding for R&D activities are creating various lucrative opportunities for market growth over the forecasting years. However, the high cost of IVD tests stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Infectious Disease In Vitro Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the rising emphasis on disease surveillance by conducting various tests and early diagnostics, geographic expansion of key players, along with the presence of favorable regulatory framework across the region. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as increasing population, rising prevalence of target diseases and infections, and rising healthcare expenditure are bolstering regional market growth in the forthcoming years.
Major market players included in this report are:
QIAGEN
bioMйrieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Recent Developments in the Market:
In January 2020, Quest Diagnostics entered into a collaborative agreement with Memorial Hermann Health System to offer enhanced, high-quality, cost-efficient, and innovative diagnostic services for 21 hospital laboratories across the Huston region. The objective of this initiative is geographical expansion.
In June 2022, Eurobio Scientific declared the introduction of two novel tests for SARS-CoV-2 (for variants Omicron BA.2, BA.1, and BA.4/BA.5) and Monkeypox in France.
Global Infectious Disease In Vitro Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Application, Technology, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Instruments
Reagents
Software
By Application:
Respiratory Virus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis
COVID-19
Others
By Technology:
Immunoassay
Molecular Diagnostics
Others
Microbiology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Infectious Disease In Vitro Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Infectious Disease In Vitro Diagnostics Market, by Product, 2019-2029 (USD Billion)
1.2.3. Infectious Disease In Vitro Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Infectious Disease In Vitro Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET DYNAMICS
3.1. Infectious Disease In Vitro Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population
3.1.1.2. Rising incidences of target infections
3.1.2. Market Challenges
3.1.2.1. High cost of IVD tests
3.1.3. Market Opportunities
3.1.3.1. Growing demand for PoC facilities
3.1.3.2. Increasing funding for R&D activities
CHAPTER 4. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Infectious Disease In Vitro Diagnostics Market by Product, Performance - Potential Analysis
6.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
6.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
6.4.1. Instruments
6.4.2. Reagents
6.4.3. Software
CHAPTER 7. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Infectious Disease In Vitro Diagnostics Market by Application, Performance – Potential Analysis
7.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
7.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
7.4.1. Respiratory Virus
7.4.2. TB and Drug-resistant TB
7.4.3. Gastro-intestinal Panel Testing
7.4.4. HIV
7.4.5. Hepatitis
7.4.6. COVID-19
7.4.7. Others
CHAPTER 8. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1. Market Snapshot
8.2. Global Infectious Disease In Vitro Diagnostics Market by Technology, Performance - Potential Analysis
8.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
8.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
8.4.1. Immunoassay
8.4.2. Molecular Diagnostics
8.4.3. Others
8.4.4. Microbiology
CHAPTER 9. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Infectious Disease In Vitro Diagnostics Market, Regional Market Snapshot
9.2. North America Infectious Disease In Vitro Diagnostics Market
9.2.1. U.S. Infectious Disease In Vitro Diagnostics Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Infectious Disease In Vitro Diagnostics Market
9.3. Europe Infectious Disease In Vitro Diagnostics Market Snapshot
9.3.1. U.K. Infectious Disease In Vitro Diagnostics Market
9.3.2. Germany Infectious Disease In Vitro Diagnostics Market
9.3.3. France Infectious Disease In Vitro Diagnostics Market
9.3.4. Spain Infectious Disease In Vitro Diagnostics Market
9.3.5. Italy Infectious Disease In Vitro Diagnostics Market
9.3.6. Rest of Europe Infectious Disease In Vitro Diagnostics Market
9.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Snapshot
9.4.1. China Infectious Disease In Vitro Diagnostics Market
9.4.2. India Infectious Disease In Vitro Diagnostics Market
9.4.3. Japan Infectious Disease In Vitro Diagnostics Market
9.4.4. Australia Infectious Disease In Vitro Diagnostics Market
9.4.5. South Korea Infectious Disease In Vitro Diagnostics Market
9.4.6. Rest of Asia Pacific Infectious Disease In Vitro Diagnostics Market
9.5. Latin America Infectious Disease In Vitro Diagnostics Market Snapshot
9.5.1. Brazil Infectious Disease In Vitro Diagnostics Market
9.5.2. Mexico Infectious Disease In Vitro Diagnostics Market
9.6. Rest of The World Infectious Disease In Vitro Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. QIAGEN
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. bioMйrieux SA
10.2.3. F. Hoffmann-La Roche, Ltd.
10.2.4. Hologic, Inc. (Gen-Probe)
10.2.5. Abbott
10.2.6. Quidel Corp.
10.2.7. Siemens Healthineers AG
10.2.8. Bio-Rad Laboratories, Inc.
10.2.9. Danaher Corp.
10.2.10. OraSure Technologies, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Infectious Disease In Vitro Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Infectious Disease In Vitro Diagnostics Market, by Product, 2019-2029 (USD Billion)
1.2.3. Infectious Disease In Vitro Diagnostics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Infectious Disease In Vitro Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET DYNAMICS
3.1. Infectious Disease In Vitro Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population
3.1.1.2. Rising incidences of target infections
3.1.2. Market Challenges
3.1.2.1. High cost of IVD tests
3.1.3. Market Opportunities
3.1.3.1. Growing demand for PoC facilities
3.1.3.2. Increasing funding for R&D activities
CHAPTER 4. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Infectious Disease In Vitro Diagnostics Market by Product, Performance - Potential Analysis
6.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
6.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
6.4.1. Instruments
6.4.2. Reagents
6.4.3. Software
CHAPTER 7. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Infectious Disease In Vitro Diagnostics Market by Application, Performance – Potential Analysis
7.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
7.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
7.4.1. Respiratory Virus
7.4.2. TB and Drug-resistant TB
7.4.3. Gastro-intestinal Panel Testing
7.4.4. HIV
7.4.5. Hepatitis
7.4.6. COVID-19
7.4.7. Others
CHAPTER 8. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
8.1. Market Snapshot
8.2. Global Infectious Disease In Vitro Diagnostics Market by Technology, Performance - Potential Analysis
8.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
8.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
8.4.1. Immunoassay
8.4.2. Molecular Diagnostics
8.4.3. Others
8.4.4. Microbiology
CHAPTER 9. GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Infectious Disease In Vitro Diagnostics Market, Regional Market Snapshot
9.2. North America Infectious Disease In Vitro Diagnostics Market
9.2.1. U.S. Infectious Disease In Vitro Diagnostics Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Infectious Disease In Vitro Diagnostics Market
9.3. Europe Infectious Disease In Vitro Diagnostics Market Snapshot
9.3.1. U.K. Infectious Disease In Vitro Diagnostics Market
9.3.2. Germany Infectious Disease In Vitro Diagnostics Market
9.3.3. France Infectious Disease In Vitro Diagnostics Market
9.3.4. Spain Infectious Disease In Vitro Diagnostics Market
9.3.5. Italy Infectious Disease In Vitro Diagnostics Market
9.3.6. Rest of Europe Infectious Disease In Vitro Diagnostics Market
9.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Snapshot
9.4.1. China Infectious Disease In Vitro Diagnostics Market
9.4.2. India Infectious Disease In Vitro Diagnostics Market
9.4.3. Japan Infectious Disease In Vitro Diagnostics Market
9.4.4. Australia Infectious Disease In Vitro Diagnostics Market
9.4.5. South Korea Infectious Disease In Vitro Diagnostics Market
9.4.6. Rest of Asia Pacific Infectious Disease In Vitro Diagnostics Market
9.5. Latin America Infectious Disease In Vitro Diagnostics Market Snapshot
9.5.1. Brazil Infectious Disease In Vitro Diagnostics Market
9.5.2. Mexico Infectious Disease In Vitro Diagnostics Market
9.6. Rest of The World Infectious Disease In Vitro Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. QIAGEN
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. bioMйrieux SA
10.2.3. F. Hoffmann-La Roche, Ltd.
10.2.4. Hologic, Inc. (Gen-Probe)
10.2.5. Abbott
10.2.6. Quidel Corp.
10.2.7. Siemens Healthineers AG
10.2.8. Bio-Rad Laboratories, Inc.
10.2.9. Danaher Corp.
10.2.10. OraSure Technologies, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Infectious Disease In Vitro Diagnostics Market, report scope
TABLE 2. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 6. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Infectious Disease In Vitro Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Infectious Disease In Vitro Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Infectious Disease In Vitro Diagnostics Market, report scope
TABLE 2. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 6. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Infectious Disease In Vitro Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Infectious Disease In Vitro Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Infectious Disease In Vitro Diagnostics Market, research methodology
FIG 2. Global Infectious Disease In Vitro Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Infectious Disease In Vitro Diagnostics Market, key trends 2021
FIG 5. Global Infectious Disease In Vitro Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Infectious Disease In Vitro Diagnostics Market, porters 5 force model
FIG 7. Global Infectious Disease In Vitro Diagnostics Market, pest analysis
FIG 8. Global Infectious Disease In Vitro Diagnostics Market, value chain analysis
FIG 9. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Infectious Disease In Vitro Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Infectious Disease In Vitro Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Infectious Disease In Vitro Diagnostics Market, research methodology
FIG 2. Global Infectious Disease In Vitro Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Infectious Disease In Vitro Diagnostics Market, key trends 2021
FIG 5. Global Infectious Disease In Vitro Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Infectious Disease In Vitro Diagnostics Market, porters 5 force model
FIG 7. Global Infectious Disease In Vitro Diagnostics Market, pest analysis
FIG 8. Global Infectious Disease In Vitro Diagnostics Market, value chain analysis
FIG 9. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Infectious Disease In Vitro Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Infectious Disease In Vitro Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
